Michelle A Rait1, Judith J Prochaska2, Mark L Rubinstein3. 1. Division of Adolescent Medicine, University of California, San Francisco, San Francisco, CA, United States. 2. Stanford Prevention Research Center in the Department of Medicine at Stanford University, Stanford, CA, United States. 3. Division of Adolescent Medicine, University of California, San Francisco, San Francisco, CA, United States. Electronic address: rubinsteinm@peds.ucsf.edu.
Abstract
INTRODUCTION: With the changing landscape of tobacco products, the divide between cigarettes and cigars is obscured, so understanding adolescent reporting of cigar use is needed to improve best practices for surveillance, screening, and prevention/intervention. This study examined adolescents' reported cigar use and correlates of use. METHODS: Participants (N=186) were 13-17year old tobacco users participating in a prospective study of adolescent smoking behaviors. Measurement occurred at baseline and 24-months, and included demographics, nicotine dependence, tobacco use, and quit attempts. Cigar use was assessed as, "have you smoked a cigar in the last 30days" and by brand specific use in the past 30days. FINDINGS: Cigar use was reported by 51 adolescents (27%), and increased to 76 (41%) when identifying by brand name. African Americans (32%) were more likely to smoke cigars than whites (10%, p<.01), Asian/Pacific Islanders (3%, p=.04), and multiracial participants (24%, p=.05). Cigarette-only users smoked more per day (p=.04) and had higher cotinine levels (p=.05) than cigar users. Number of prior quit attempts (p=.84) did not differ by group. Group differences in addiction were found between cigar users and cigarette only users (p<.01). At 24months, more baseline cigar users were tobacco abstinent than cigarette only users (16% versus 7%, p<0.01, respectively). CONCLUSIONS: Assessment of brand-specific cigars nearly doubled the reporting among adolescent users. Cigar users differed from cigarette-only users in consumption and likelihood of abstinence at 24-months. For more accurate surveillance and to inform treatment considerations, surveys of adolescent tobacco use should include cigars, including brand names, in the assessment strategy.
INTRODUCTION: With the changing landscape of tobacco products, the divide between cigarettes and cigars is obscured, so understanding adolescent reporting of cigar use is needed to improve best practices for surveillance, screening, and prevention/intervention. This study examined adolescents' reported cigar use and correlates of use. METHODS:Participants (N=186) were 13-17year old tobacco users participating in a prospective study of adolescent smoking behaviors. Measurement occurred at baseline and 24-months, and included demographics, nicotine dependence, tobacco use, and quit attempts. Cigar use was assessed as, "have you smoked a cigar in the last 30days" and by brand specific use in the past 30days. FINDINGS: Cigar use was reported by 51 adolescents (27%), and increased to 76 (41%) when identifying by brand name. African Americans (32%) were more likely to smoke cigars than whites (10%, p<.01), Asian/Pacific Islanders (3%, p=.04), and multiracial participants (24%, p=.05). Cigarette-only users smoked more per day (p=.04) and had higher cotinine levels (p=.05) than cigar users. Number of prior quit attempts (p=.84) did not differ by group. Group differences in addiction were found between cigar users and cigarette only users (p<.01). At 24months, more baseline cigar users were tobacco abstinent than cigarette only users (16% versus 7%, p<0.01, respectively). CONCLUSIONS: Assessment of brand-specific cigars nearly doubled the reporting among adolescent users. Cigar users differed from cigarette-only users in consumption and likelihood of abstinence at 24-months. For more accurate surveillance and to inform treatment considerations, surveys of adolescent tobacco use should include cigars, including brand names, in the assessment strategy.
Authors: F Baker; S R Ainsworth; J T Dye; C Crammer; M J Thun; D Hoffmann; J L Repace; J E Henningfield; J Slade; J Pinney; T Shanks; D M Burns; G N Connolly; D R Shopland Journal: JAMA Date: 2000-08-09 Impact factor: 56.272
Authors: Catherine G Corey; Shanta R Dube; Bridget K Ambrose; Brian A King; Benjamin J Apelberg; Corinne G Husten Journal: Am J Prev Med Date: 2014-08 Impact factor: 5.043
Authors: J R DiFranza; J A Savageau; N A Rigotti; K Fletcher; J K Ockene; A D McNeill; M Coleman; C Wood Journal: Tob Control Date: 2002-09 Impact factor: 7.552
Authors: Grace Kong; MeLisa R Creamer; Patricia Simon; Dana A Cavallo; Jennifer Cornacchione Ross; Josephine T Hinds; Howard Fishbein; Kevin Gutierrez Journal: Addict Behav Date: 2019-05-04 Impact factor: 3.913
Authors: Erika S Trapl; Danielle O'Rourke-Suchoff; Laura D Yoder; Leslie E Cofie; Jean L Frank; Craig S Fryer Journal: Am J Prev Med Date: 2016-10-04 Impact factor: 5.043
Authors: Paul T Harrell; Syeda Mahrukh Hussnain Naqvi; Andrew D Plunk; Ming Ji; Silvia S Martins Journal: Am J Drug Alcohol Abuse Date: 2016-09-26 Impact factor: 3.829
Authors: Catherine G Corey; Enver Holder-Hayes; Anh B Nguyen; Cristine D Delnevo; Brian L Rostron; Maansi Bansal-Travers; Heather L Kimmel; Amber Koblitz; Elizabeth Lambert; Jennifer L Pearson; Eva Sharma; Cindy Tworek; Andrew J Hyland; Kevin P Conway; Bridget K Ambrose; Nicolette Borek Journal: Nicotine Tob Res Date: 2018-11-15 Impact factor: 4.244